- Investing Ideas
- Belgian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Belgian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
3
0 new
Mid-Large Cap Stocks
3 companies
Financière de Tubize
Market Cap: €9.3b
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium.
TUB
€209.80
7D
3.0%
1Y
47.7%
UCB
Market Cap: €46.8b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€245.80
7D
3.3%
1Y
37.4%
argenx
Market Cap: €49.4b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€789.80
7D
4.8%
1Y
54.3%